Estrella Immunopharma extends equity line with White Lion to Dec 2025, adds rapid share purchase mechanism

Estrella Immunopharma, Inc.

Amendment extends existing up-to-$50M stock purchase agreement from Dec 30, 2024 to Dec 30, 2025.
New 'Rapid Purchase' mechanism allows expedited share sales at lowest traded price on notice date.
Rapid purchase limit is the lesser of 20% of average daily trading volume or investment limit divided by highest close over five days.
Standard purchase discount remains 97% (up to $25M) then 98%; rapid purchases use lowest traded price (0% discount).
Company delivers Rapid Purchase Notice by 11:00 a.m. NY time with concurrent DWAC transfer; payment due next business day by 5 p.m.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.